Notice: Fall 2017 exams affected by natural disasters... More >

Expand/Collapse Close

ABIM knows that we have many physicians whose lives have been upended by recent natural disasters. If you live or work near an affected area, we understand that the weather may have impacted your ability to take your Fall 2017 exam as scheduled. We have developed a series of options to help you get through this process as smoothly as possible. If you have any questions, please call us at 1-800-441-ABIM (2246) or email request@abim.org.

American Board of Internal Medicine home page

MOC is a professionally determined standard that attests that an internist is staying current in knowledge and practice throughout his/her career.

Initial Certification indicates that physicians have met rigorous standards through intensive study, accredited training and evaluation and that they have the clinical judgment, skills and attitudes essential for the delivery of excellent patient care.

For more than 75 years, Certification by ABIM has stood for the highest standard in internal medicine and its 20 subspecialties.

Cardiovascular Board

Olakunle Akinboboye, MD, Chair

Dr. Akinboboye is board certified in Cardiovascular Disease and Sleep Medicine. He is an Associate Professor of Clinical Medicine at the Weill Medical College of Cornell University, New York. He is also the Medical Director of Queens Heart Institute/Laurelton Heart Specialist P.C. in Rosedale, Queens, New York.

Dr. Akinboboye is Chair of the American Board of Internal Medicine Cardiovascular Board and a member of the ABIM Council. He is also a member of the Association of Black Cardiologists (ABC) Executive Committee, where he serves as Chair of the Clinical Trials Committee. He also serves on the International Board of Governors of the American College of Cardiology (Liason for Africa). He served as the President of the ABC from 2012 to 2014.

He received a humanitarian award from the College of Medicine at University of Ibadan in Nigeria in 2005 for his ongoing efforts to spread expertise in the techniques of cardiopulmonary resuscitation in Nigeria. He also received an award from ABC for his dedicated service as a board member from 1999 to 2005.

Dr. Akinboboye received his medical degree from the College of Medicine at the University of Ibadan. He completed his internal medicine residency and part of his cardiology fellowship at the Nassau County Medical Center, State University of New York at Stony Brook. He subsequently moved to Columbia University, where he completed his fellowship in cardiology with one year of dedicated training in nuclear cardiology and another year of training in advanced echocardiography. Dr. Akinboboye obtained a master's degree in public health from Columbia University. He also received a master's degree in business administration from Columbia Business School.

As of January 2017, Dr. Akinboboye reported the following external relationships:

Funding for clinical trial expenses and staff, paid to Queens Heart Institute, from the following companies:

  • AstraZeneca, for a study of the effects of exenatide in lowering cardiovascular events in patients with type 2 diabetes mellitus (EXSCEL).
  • Novartis, for a study of the effectiveness of angiotensin-neprilysin inhibition versus enalapril in heart failure (PARADIGM-HF).

Service on a research-related expert panel or advisory board, paid to Queens Heart Institute, for the following companies, with compensation as listed:

  • Alnylam Pharmaceuticals, Inc., to advise on a study of ALN-TTRsc, a novel RNA interference therapeutic for the treatment of familial amyloidotic cardiomyopathy, receiving travel reimbursement and honoraria.

Teaching in satellite symposia funded by the following companies, with compensation as listed:

  • Arbor Pharmaceuticals, for a discussion of the use of fixed-dose isosorbide dinitrate/hydralazine in the management of self-identified black patients with congestive heart failure and management of hypertension with EDARBI/EDARBYCLOR, receiving honoraria.
  • Arbor Pharmaceuticals, for teaching on the management of hypertension with azilsartan medoxomil and azilsartan medoxomil plus chlorthalidone, receiving honoraria.
  • Takeda, for teaching about the management of type 2 diabetes with alogliptin, receiving honoraria.

Theodore A. Bass, MD

Dr. Bass, a board certified internist, cardiologist and interventional cardiologist, currently serves as Professor of Medicine at the University of Florida (UF) College of Medicine, and Chief of Cardiology and Medical Director of the Cardiovascular Center at the UF Health-Jacksonville campus. He has served as the Interventional Cardiology Fellowship Training Program Director for the past 15 years. He is an actively practicing interventional cardiologist specializing in complex coronary interventions. His academic interests have involved interventional device and pharmacological research and helping to define optimal methods to ensure physician quality performance.

Currently, Dr. Bass serves as a member of the American Board of Internal Medicine (ABIM) Cardiovascular Board, and previously served as a member of the ABIM Cardiovascular Board Interventional Cardiology Exam Committee, a committee which he had chaired for four years. He a past President of the Society for Cardiovascular Angiography and Interventions and served as Vice-Chair of the American College of Cardiology Foundation/American Heart Association/Society for Cardiovascular Angiography and Interventions 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures. He currently serves on the editorial boards of three interventional cardiovascular journals.

Dr. Bass earned his medical degree at the Warren Alpert Medical School of Brown University. He did his medicine residency training at the Mayo Clinic in Rochester, Minnesota and his general cardiology fellowship at Boston University Medical Center. He later completed his interventional cardiology training at Brown University.

As of January 2017, Dr. Bass reported the following external relationships:

Research activities:

Clinical trials, with funding for clinical trial expenses and clinical research staff, paid directly to the University of Florida, from the following company:

  • Abbott, for the ABSORB III trial of a bio-absorbable stent.

Matthew Bosner, MD

Dr. Matthew Bosner, a board certified internist and cardiologist, is the Director of Cardiology and Cardiovascular Imaging, Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, a critical access hospital and rural health clinic system 60 miles south of St. Louis. Dr. Bosner maintains an active general cardiology practice. He serves as the Liaison for Rural Cardiovascular Services for the BJC Medical Group, one of the largest medical systems in the Midwest. He is responsible for coordinating cardiovascular services and imaging in the extensive network of rural and smaller community hospitals and the tertiary urban medical centers.

After completing his training, Dr. Bosner remained on the full-time faculty of Washington University School of Medicine as a National Institutes of Health and American Hospital Association independently funded primary investigator in basic and clinical research, focusing on intestinal lipid metabolism, atherosclerosis and vascular medicine. He founded and co-Directed the Marfan Clinic and related Aortic Inherited Diseases Clinic at Washington University and directed the Lipid and Atherosclerosis Clinic at the Jewish Hospital of St. Louis. Dr. Bosner transitioned to private practice in noninvasive cardiology. His patient care model is comprehensive preventive team-based noninvasive cardiovascular medicine.

Dr. Bosner is certified by the American Board of Internal Medicine (ABIM), American Society of Hypertension, American Society of Echocardiography and American Society of Nuclear Cardiology and is a fellow of the American College of Cardiology and American College of Physicians. He serves as a member of the ABIM Cardiovascular Board.

He earned his medical degree at the University of Texas Medical School and completed his internal medicine and cardiology training at Washington University School of Medicine, St. Louis, Missouri.

As of January 2017, Dr. Bosner reported no external relationships.

John Brush Jr., MD

Dr. Brush, a board certified internist, cardiologist and interventional cardiologist, is a Professor of Medicine at Eastern Virginia Medical School. Since 1992, he has practiced cardiology in Norfolk, Virginia and in 2012, his group became Sentara Cardiology Specialists.

From 1988 to 1992, Dr. Brush was an Assistant Professor of Medicine at Boston University School of Medicine. Prior to that, from 1985 to 1988, he was a Senior Investigator and Staff Cardiologist with the Cardiology Branch of the National Institutes of Health in Bethesda, Maryland.

Dr. Brush's primary areas of clinical interest are coronary intervention for patients with acute coronary syndromes, and the diagnosis and treatment of patients with a full spectrum of cardiac disorders. In addition to a busy clinical practice, he has maintained an interest in cardiovascular outcomes research and has led quality improvement initiatives at the local, state and national level. In 2013, he authored an iBook on medical reasoning entitled, “The Science of the Art of Medicine.”

Dr. Brush has been active with the American College of Cardiology (ACC). From 2006 to 2009, he was President of the Virginia ACC Chapter and served on the ACC Board of Governors. From 2010 to 2015, he served as a member of the ACC Board of Trustees. He is also a member of the American Board of Internal Medicine Cardiovascular Board and has served on the boards of the Health Care Incentives Improvement Institute and Prometheus Payment, Inc.

Dr. Brush graduated from Hampden-Sydney College in 1976 and earned his medical degree from the University of Virginia in 1980. He trained in internal medicine at the University of Vermont School of Medicine and in cardiology at Yale University School of Medicine.

As of January 2017, Dr. Brush reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed below:

  • Dementi Milestone Publishing, Apple iBooks, receiving payments for sales of the book, The Science of the Art of Medicine.

Dr. Brush serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, serving as a member of the Finance Committee, Investments Subcommittee and Competency Management Committee, receiving reimbursement for travel expenses.

Vincent Bufalino, MD

Dr. Bufalino is a board certified internist and cardiologist. He runs a 150-physician cardiology group in Chicago. He is the Senior Vice President for the Advocate Cardiovascular Institute and Senior Medical Director of Advocate Medical Group, a 1,400 physician multi-disciplinary practice. He has served as Medical Director of the Edward Heart Hospital, the second busiest cardiac catheterization lab in Illinois. His clinical interests have been in preventive cardiology along with sudden cardiac death. Additionally, Dr. Bufalino has built one of the largest automated external defibrillator networks in the country.

Dr. Bufalino is a 30-year volunteer for the American Heart Association (AHA). He has been active at the local, regional and national levels and chaired many AHA committees including Advocacy, Emergency Cardiac Care, International and The Guideline Advantage. He had several terms on its National Board, as well as serving as President of the Chicago and Midwest Affiliate. He was named Physician of the Year for the AHA and given both the Chairman's Award in 2005 and the Gold Heart Award in 2008. He is also a member of the American Board of Internal Medicine Cardiovascular Board.

Dr. Bufalino earned his medical degree from Loyola Stritch School of Medicine in 1978. There, he completed a residency in internal medicine and a fellowship in cardiovascular disease.

As of January 2017, Dr. Bufalino reported the following external relationships:

Dr. Bufalino serves in a significant role with the following organization, receiving reimbursement or compensation as listed:

  • American Heart Association, Chair of the Expert Panel on Healthcare Reform, receiving reimbursement for travel expenses.

Hugh Calkins, MD

Dr. Calkins, a board certified cardiologist and electrophysiologist, is the Nicholas J. Fortuin M.D. Professor of Cardiology and Professor of Medicine at the Johns Hopkins University School of Medicine. He also is the Director of the Clinical Electrophysiology Laboratory, the Arrhythmia Service and the Arrhythmogenic Right Ventricular Dysplasia Program at the Johns Hopkins Hospital. His academic career has focused on clinical electrophysiology.

Dr. Calkins' first faculty position was at the University of Michigan where he served as Director of the Pacemaker and Device Service. He was recruited to Johns Hopkins in 1992 as an Associate Professor of Medicine and Director of the Electrophysiology Service.

Currently, Dr. Calkins serves as a member of the American Board of Internal Medicine (ABIM) Cardiovascular Board and is former Chair of the ABIM Clinical Cardiac Electrophysiology Self-Assessment Committee. He has previously served as a member of the ABIM Cardiovascular Board Clinical Cardiac Electrophysiology Exam Committee. Dr. Calkins is a past President of the Heart Rhythm Society.

Dr. Calkins graduated magna cum laude with highest honors in chemistry from Williams College. He then attended Harvard Medical School before training in internal medicine at the Massachusetts General Hospital. He received his cardiology fellowship training at Johns Hopkins. Dr. Calkins trained in electrophysiology at Johns Hopkins and at the University of Michigan.

As of January 2017, Dr. Calkins reported the following external relationships:

Funding for clinical trial expenses and staff and/or honoraria from the following company:

  • Boehringer Ingelheim, serving as the Principal Investigator on a multi-center clinical trial studying atrial fibrillation ablation, receiving honoraria.

Service on data and safety monitoring boards for the following company, with no compensation to date:

  • St. Jude, for a ventricular tachycardia ablation trial.

Service on a research-related expert panel or advisory board for the following company, with honoraria:

  • AtriCure, for advisory role to help design a clinical trial of surgical atrial fibrillation ablation.

Work as an author or editor for following company, with compensation as listed:

  • UpToDate, receiving compensation for reviewing manuscripts.

Dr. Calkins serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • Heart Rhythm Society, Executive Committee Member, receiving reimbursement for travel expenses.

Frederick A. Masoudi, MD

Dr. Masoudi, a board certified cardiologist, is Professor of Medicine with tenure in the Division of Cardiology at the University of Colorado Anschutz Medical Campus. His position includes general clinical cardiology, health services research, medical student and resident education and research mentoring.

Currently, Dr. Masoudi serves as a member of the American Board of Internal Medicine Cardiovascular Board. He is also a member of Board of Trustees of the American College of Cardiology (ACC), the Management Board of the ACC's National Cardiovascular Data Registries (NCDR), the Chair of the NCDR Science and Quality Oversight Committee and a member of the ACC Lifelong Learning Oversight Committee. He is the immediate past Chair of the American Heart Association Council on Quality of Care and Outcomes Research.

Dr. Masoudi earned an undergraduate degree in chemistry from Amherst College, received his medical degree from the Johns Hopkins University School of Medicine and served as intern, resident, and Chief Resident in internal medicine at the University of California, San Francisco. He completed a cardiology fellowship and a master's degree in public health at the University of Colorado.

As of January 2017, Dr. Masoudi reported the following external relationships:

Work as an author or editor for the following companies, with compensation as listed:

  • American Heart Association, for work as Associate Editor of Circulation: Cardiovascular Quality and Outcomes, receiving compensation as an editor.
  • Massachusetts Medical Society, for work as Associate Editor of Journal Watch Cardiology, receiving compensation as an editor.

Dr. Masoudi serves in significant roles with the following organizations, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Board of Trustees and Chief Science Officer, National Cardiovascular Data Registries (NCDR), receiving reimbursement for travel expenses and a per diem for attending board meetings, and a contract for his work with the NCDR.
  • American Heart Association, Immediate Past Chair, Council on Quality of Care and Outcomes Research (QCOR) and Chair of the Nomination Committee for the QCOR Council, receiving reimbursement for travel expenses.

Dr. Masoudi receives funding provided to the University of Colorado as described from the following organizations:

  • American College of Cardiology, for a study of outcomes of patients receiving implantable cardioverter defibrillators for primary prevention, receiving funding for research staff, project expenses and salary support.
  • John A. Hartford Foundation, for a project on redesigning care for older patients with complex health needs, receiving funding for salary support.

Dr. Masoudi receives consulting fees from Yale University for his work supporting career development for early career investigator in cardiovascular health outcomes research, paid to the University of Colorado.

Susan A. Moore, ARNP, MSN

Ms. Moore, a board certified Adult-Gerontology Primary Care Nurse Practitioner, practices at Sanger Heart & Vascular Institute in Charlotte, North Carolina. For the past 20 years, her career has centered on the care of cardiovascular patients and the education of nurses and other allied health professionals. Much of her time has been devoted to the care of patients with heart failure.

Ms. Moore currently serves as the Coordinator for the Carolinas HealthCare System's Center for Advanced Practice Cardiology Fellowship. She has served as faculty in the School of Nursing at the University of Southern Maine. Ms. Moore was instrumental in the development of the Heart Failure Program at Carolinas Medical Center and was Lead Program Coordinator for seven years prior to pursuing her master's degree.

She is a member of the American Board of Internal Medicine Cardiovascular Board. She is also the current President of the Metrolina Coalition of Nurse Practitioners, and was a past Treasurer, Board member and Chair of the Annual Meeting Committee of the American Association of Heart Failure Nurses.

Ms. Moore earned her bachelor of science degree in nursing from the University of North Carolina at Charlotte in 1993. She completed her master of science degree in nursing with a dual degree as an Adult Nurse Practitioner and Clinical Nurse Specialist at the University of North Carolina at Charlotte in 2004. She obtained board certification as an adult nurse practitioner in 2004 and gerontological nurse practitioner in 2011.

As of January 2017, Ms. Moore reported the following external relationships:

Ms. Moore serves in a significant role with the following organization, receiving compensation as listed:

  • Metrolina Coalition of Nurse Practitioners, Treasurer, without compensation.

Ms. Moore is a guest lecturer for the American Association of Heart Failure Nurses annual review course for the Certified Heart Failure Nurse Exam for non-physicians. She receives reimbursement for travel expenses.

Kristen K. Patton, MD

Dr. Patton, board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology, is an Associate Professor of Medicine in the Division of Cardiology and Arrhythmia Section at the University of Washington. She has been Associate Director of the Clinical Cardiac Electrophysiology program since 2011, and was named Program Director in 2014. Her research interests include learning, assessment and simulation, and the epidemiology and genetics of atrial fibrillation and sudden cardiac death.

Dr. Patton serves as a member of the American Board of Internal Medicine Cardiovascular Board. She was named to the American College of Cardiology Foundation Emerging Faculty Program in 2010, and was a University of Washington Teaching Scholar in 2012. She is participating in the Medical Education Research Certificate program through the University of Washington Center for Leadership and Innovation in Medical Education. She serves on the Heart Rhythm Society Scientific and Clinical Documents Committee, and is the Chair of the Education Workgroup for the American College of Cardiology Electrophysiology Council.

She earned a bachelor's degree from the University of Chicago, and her medical degree from Oregon Health & Sciences University. She completed an internal medicine residency at Massachusetts General Hospital, a cardiology fellowship at Brigham and Women's Hospital and Massachusetts General Hospital, and an electrophysiology fellowship at Massachusetts General Hospital. She joined the faculty at University of Washington in 2004.

As of January 2017, Dr. Patton reported the following external relationships:

Dr. Patton serves in significant roles with the following organizations, receiving compensation as listed:

  • Accreditation Council for Graduate Medical Education, Internal Medicine Review Committee, receiving reimbursement for travel expenses.
  • American College of Cardiology, Electrophysiology Council, Education Workgroup, Bradycardia Guidelines Writing Group, and Lifelong Learning Advanced Training Statement for Electrophysiology, receiving reimbursement for travel expenses.
  • American Heart Association, Arrhythmias and Electrocardiogram Committee Chair, without compensation.
  • Heart Rhythm Society, member of the Scientific and Clinical Documents Committee, without compensation.

Dr. Patton also serves as a member of the Food and Drug Administration’s Circulatory System Devices Panel, receiving travel reimbursement for travel expenses and a per diem for attending meetings.

Philip E. Stauffer

Mr. Stauffer is an Aviation Safety Inspector employed by the Federal Aviation Administration (FAA) and works in the Flight Standards National Field Office. This division is a national field organization responsible for designing, developing and deploying Flight Standards Service (AFS) systems for certification, surveillance and resolution of safety issues for air operators, and air agencies. He has been a member of several teams tasked with developing the strategy, communication efforts and tools for a new risk-based oversight system. Mr. Stauffer's current job involves traveling to field offices providing training and implementation support. He has been with the FAA for more than eight years and in 2009, he was named the National Field Inspector of the Year-Avionics.

Prior to joining the FAA, Mr. Stauffer had more than 25 years of experience in aircraft maintenance for three major airlines—Eastern Airlines, US Airways and JetBlue Airways— both on the flight line and in management roles. These roles have included managing the Maintenance Operations Control Center which had oversight of the airline's fleet of aircraft and provided technical safety-of-flight assistance to flight crew and technicians. Mr. Stauffer is a member of the American Board of Internal Medicine Cardiovascular Board.

Mr. Stauffer attended college at Millersville State University, Millersville, Pennsylvania, and the University of Nairobi, Nairobi, Kenya. He graduated from Vaughn College of Aeronautics and Technology (formerly Academy of Aeronautics) in New York City.

As of January 2017, Mr. Stauffer reported no external relationships.

Karen K. Stout, MD

Dr. Stout is a board certified cardiologist and is Director of the Adult Congenital Heart Disease Program and Director of the Adult Congenital Heart Disease (ACHD) Fellowship at the University of Washington Medical Center and Seattle Children's Hospital. She is a Professor of Cardiology in Medicine and Pediatrics at the University of Washington. Her academic interests are adult congenital heart disease, pregnancy and heart disease and echocardiography.

Dr. Stout is a member of the American Board of Internal Medicine (ABIM) Cardiovascular Board Adult Congenital Heart Disease Exam Committee and the ABIM Cardiovascular Board. She was Chair of the 2015 American College of Cardiology (ACC)/American Heart Association (AHA) Care of Adults with Congenital Heart Disease Guidelines Writing Committee and has chaired or been a member of several AHA scientific statements regarding congenital heart disease. She is a member of the ACC Adult Congenital and Pediatric Cardiology Committee and is Chair of the AHA ACHD Committee.

Dr. Stout earned her medical degree from the University of Arizona. She completed internal medicine residency and chief residency at Oregon Health and Sciences University and Cardiology fellowship at the University of Washington. She completed a congenital heart disease fellowship at Seattle Children's Hospital.

As of January 2017, Dr. Stout reported the following external relationships:

Work as an author or editor for following companies, with compensation as listed:

  • Elsevier, receiving royalties for a textbook that she edited.
  • UpToDate, receiving compensation for authorship.

Dr. Stout serves in significant roles with the following organizations, receiving compensation as listed:

  • American College of Cardiology, Member of Adult Congenital and Pediatric Cardiology Council, without compensation.
  • American Congenital Heart Association, Medical Advisory Board, without compensation.
  • American Heart Association, Puget Sound Chapter Board of Directors, without compensation.

James E. Tcheng, MD

Dr. Tcheng, a board certified internist, cardiologist, interventional cardiologist and informatician, is a Professor of Medicine and Professor of Community and Family Medicine (Informatics) at Duke University in Durham, North Carolina.

Currently, Dr. Tcheng serves as Chair of the American Board of Internal Medicine (ABIM) Cardiovascular Board Interventional Cardiology Exam Committee and is a member of the ABIM Cardiovascular Board. He is a member of the Lifelong Education Committee of the American College of Cardiology (ACC) and the ACC Publications and Editorial Coordination Committee, and the National Cardiovascular Disease Registry. He serves as Chair of the ACC Informatics and Health Information Technology Task Force and the ACC Digital Steering Committee.

He is an accomplished clinical trialist of cardiovascular therapeutics, particularly antithrombotic and interventional therapies in coronary artery disease. More recently, his career has focused on the representation and application of knowledge in electronic health record systems through the use of informatics.

Dr. Tcheng received his medical degree from Johns Hopkins University, and he completed his residency in internal medicine at Barnes Hospital, Washington University, St. Louis. He completed fellowship training in cardiology and interventional cardiology at Duke University.

As of January 2017, Dr. Tcheng reported the following external relationships:

Service on data and safety monitoring board for the following company, with honoraria:

  • AstraZeneca, for a study evaluating ticagrelor with aspirin versus ticagrelor alone in high-risk patients after coronary intervention.

Service on a research-related expert panel or advisory board for the following companies, with compensation as listed:

  • Philips Medical Systems, as a subject matter expert on the design and development of next generation cardiovascular information systems, receiving reimbursement for travel and honoraria.
  • Cardiovascular Systems, Inc., as a subject matter expert on the design and evaluation of clinical studies to advance the treatment of peripheral vascular and cardiovascular disease.

Consulting on design of new drugs or devices, clinical trials, the use of specific agents or other research-related activities for the following company, with reimbursement for travel expenses and honoraria

  • International Guidelines Central, providing consultative guidance in the redesign and updating of their web product portfolio for this publisher of Guideline “Pocket Cards.”

Work as an author or editor for following company, with compensation as listed:

Humana Press, receiving royalties for serving as an editor for Primary Angioplasty in Acute Myocardial Infarction.

Dr. Tcheng serves in significant roles with the following organization, receiving reimbursement or compensation as listed:

  • American College of Cardiology, Committee Chair of Digital Steering Committee & Informatics and Health Information Technology Task Force, and National Cardiovascular Disease Registry Board Member, and member of the Science and Quality Oversight Committee, the Data Standards Task Force, the Lifelong Learning Oversight Committee, the Cardiovascular Training Council, and the Publications and Educational Coordination Committee, receiving reimbursement for travel expenses.